Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

7,975 public trials 742 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease

NCT00361959

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Grimmenstein, Austria
  • GSK Investigational Site Mödling, Austria
  • GSK Investigational Site Salzburg, Austria
  • GSK Investigational Site Vienna, Austria
View all 166 locations
View Trial Details
Completed

Study Of Asthma In Patients Of African Descent

NCT00102765

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Mobile, Alabama, United States
View all 75 locations
View Trial Details
Completed

Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) Axis

NCT01086410

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Cypress, California, United States
  • GSK Investigational Site Huntington Beach, California, United States
  • GSK Investigational Site Oklahoma City, Oklahoma, United States
  • GSK Investigational Site San Antonio, Texas, United States
View all 17 locations
View Trial Details
Completed

Fall Epidemic Viral Pediatric Study

NCT01192178

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Fresno, California, United States
  • GSK Investigational Site Granada Hills, California, United States
View all 38 locations
View Trial Details
Completed

HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and Adolescents

NCT01147848

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Huntington Beach, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Riverside, California, United States
View all 63 locations
View Trial Details
Completed

Randomised Study Comparing the Effects of Inhaled Fluticasone Furoate (FF)/Vilanterol (VI; GW642444M) Combination and FF on an Allergen Induced Asthmatic Response

NCT01128569

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Berlin, State of Berlin, Germany
  • GSK Investigational Site Wellington, New Zealand
  • GSK Investigational Site London, United Kingdom
  • GSK Investigational Site Manchester, United Kingdom
View Trial Details
Completed

Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The AURA Study (BY217/M2-124)

NCT00297102

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Altana Pharma/Nycomed Investigational Site Fullerton, California, United States
  • Altana Pharma/Nycomed Investigational Site Los Angeles, California, United States
  • Altana Pharma/Nycomed Investigational Site Los Angeles, California, United States
  • Altana Pharma/Nycomed Investigational Site Palmdale, California, United States
View all 179 locations
View Trial Details

Related conditions